All terms in GO

Label Id Description
negative regulation of nitric oxide metabolic process GO_1904406 [Any process that stops, prevents or reduces the frequency, rate or extent of nitric oxide metabolic process.]
positive regulation of salivary gland formation by mesenchymal-epithelial signaling GO_0060639 [Any process that induces the formation of the salivary gland field by means of the secretion of a signal by a mesenchymal cell and its reception and interpretation by an epithelial cell resulting in it adopting the identity of a salivary gland bud cell.]
negative regulation of (1->3)-beta-D-glucan biosynthetic process GO_0060636 [Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.]
positive regulation of lactation by mesenchymal-epithelial cell signaling GO_0060637 [The process that increases the rate, frequency, or extent of lactation as a result of the secretion of a signal from the mammary fat and its reception by a mammary epithelial cell.]
positive regulation of lactation GO_1903489 [Any process that activates or increases the frequency, rate or extent of lactation.]
macrophage migration inhibitory factor receptor complex GO_0035692 [A protein complex that binds macrophage migration inhibitory factor. Comprises CD74 and CD44 cell surface proteins.]
NOS2-CD74 complex GO_0035693 [A protein complex comprising nitric oxide synthase 2 and CD74. This stable complex formation is thought to prevent CD74 degradation by caspases.]
GO_0035690 GO_0035690
macrophage migration inhibitory factor signaling pathway GO_0035691 [The series of molecular signals initiated by macrophage migration inhibitory factor binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.]
GO_0045011 GO_0045011
obsolete MHC class II receptor activity GO_0045012 [OBSOLETE. A major histocompatibility complex class II receptor. These display processed antigens from virally-infected or transformed cells. Class-II-positive cells ('antigen-presenting cells') can take up antigens from outside by endocytosis, degrade them into small peptides, and re-export the peptides (now bound to MHC class II protein) to the cell surface. These peptide-MHC class II complexes can then be recognized by specific CD4+ lymphocytes.]
carbon catabolite repression GO_0061985 [A process in which the presence of one carbon source leads to the modulation of the frequency, rate, or extent of the metabolism of other carbon sources.]
negative regulation of transcription by glucose GO_0061986 [Any process involving glucose that decreases the frequency, rate or extent or transcription.]
HDEL sequence binding GO_0045015 [Binding to a HDEL sequence, the C terminus tetrapeptide sequence His-Asp-Glu-Leu found in proteins that are to be retained in the endoplasmic reticulum.]
magnesium ion transmembrane transport GO_1903830 [The directed movement of magnesium ion across a membrane.]
glycerolipid biosynthetic process GO_0045017 [The chemical reactions and pathways resulting in the formation of glycerolipids, any lipid with a glycerol backbone.]
glycerolipid metabolic process GO_0046486 [The chemical reactions and pathways involving glycerolipids, any lipid with a glycerol backbone. Diacylglycerol and phosphatidate are key lipid intermediates of glycerolipid biosynthesis.]
retrograde transport, vacuole to Golgi GO_0045018 [The directed movement of substances from the vacuole to the trans-Golgi network; this occurs in yeast via the prevacuolar/endosomal compartment.]
regulation of prostatic bud formation GO_0060685 [Any process that modulates the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.]
negative regulation of prostatic bud formation GO_0060686 [Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.]